Hims & Hers Health, Inc.

$HIMS stock is sliding today after Novo Nordisk abruptly cut them off from selling lower-priced Wegovy. Despite the current 33% drop in price $HIMS is still firmly in its uptrend on its weekly chart.

Share this article:

About the Author:

Hims & Hers Health, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup